Parkinson's Disease Trial, Recruiting NCT07475741 Sponsor: University of Health Sciences Lahore Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT07475741
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with early-stage Parkinson's Disease (stages 1 to 3 on a standard scale used by doctors to measure how far the condition has progressed)
  • You scored 24 or higher on a standard memory and thinking test called the MMSE, meaning your thinking and memory are generally intact
  • You are able to communicate and follow simple instructions
  • You are currently taking a medication called Levodopa/carbidopa on a regular basis

Who may not be able to join:

  • You have advanced Parkinson's Disease at stage 4 or 5 (more severe stages of the condition)
  • You have serious problems with memory or thinking ability
  • You have a history of other conditions affecting the brain, nerves, or muscles that would make it difficult to use your hands for exercise (confirm with trial site)
  • You are not taking any medication for an ongoing general health condition (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr. Nadia Naseem, Ph.D., University of Health Sciences Lahore

Phone: +92345-6627409

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Health Sciences Lahore
Registry
ClinicalTrials.gov
Start date
20 February 2026
Est. completion
1 September 2026

Where this trial is recruiting

🇵🇰 Pakistan

Primary endpoints

Box and Block Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov